| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.802 | 5.380 | 3.183 | 5.205 | 9.854 | 790 | 8.786 | - | 0 | 0 |
| Total Income - EUR | 5.802 | 5.380 | 3.183 | 5.205 | 9.854 | 790 | 8.786 | - | 0 | 5 |
| Total Expenses - EUR | 3.338 | 4.090 | 4.872 | 4.984 | 5.760 | 3.539 | 7.539 | - | 8 | 373 |
| Gross Profit/Loss - EUR | 2.464 | 1.290 | -1.690 | 221 | 4.094 | -2.749 | 1.247 | - | -8 | -369 |
| Net Profit/Loss - EUR | 2.290 | 1.128 | -1.722 | 169 | 3.995 | -2.757 | 1.084 | - | -8 | -369 |
| Employees | 1 | 1 | 2 | 3 | 1 | 1 | 1 | - | 1 | 0 |
Check the financial reports for the company - Brave Intermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 133 | 131 | 129 | 127 | 124 | 122 | 119 | - | 119 | 118 |
| Current Assets | 1.943 | 737 | 414 | 1.337 | 3.614 | 845 | 2.431 | - | 1.098 | 0 |
| Inventories | 25 | 24 | 24 | 23 | 23 | 23 | 22 | - | 22 | 0 |
| Receivables | 0 | 27 | 23 | 23 | 22 | 361 | 353 | - | 353 | 0 |
| Cash | 1.918 | 685 | 367 | 1.291 | 3.569 | 461 | 2.055 | - | 722 | 0 |
| Shareholders Funds | -707 | 429 | -1.300 | -1.096 | 2.920 | 108 | 1.189 | - | 243 | -127 |
| Social Capital | 45 | 45 | 44 | 54 | 53 | 52 | 51 | - | 51 | 50 |
| Debts | 2.782 | 440 | 1.843 | 2.560 | 818 | 859 | 1.360 | - | 974 | 246 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6831 - 6831" | |||||||||
| CAEN Financial Year |
6831
|
|||||||||
Comments - Brave Intermed Srl